Investigating the causal effect of fibroblast growth factor 23 on osteoporosis and cardiometabolic disorders: A Mendelian randomization study
The pathological excess of fibroblast growth factor 23 (FGF23) causes mineral disorders and bones. However, the causality of the FGF23…
Read More